Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,036
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media
GSK Company
Research
GSK Company
Timeline1
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms
* Decision follows systematic review, no clinical trial data
US FDA approves leucovorin for ultra- rare genetic disorder causing autism-like symptoms
* Decision follows systematic review, no clinical trial data
US FDA to expand leucovorin’s approved use, but not for autism, WaPo reports
March 10 (Reuters) - The U.S. Food and Drug Administration will announce on Tuesday that it will expand approval for leucovorin, but only for ...
GSK and Alfasigma ink agreement for worldwide rights for linerixibat
(Alliance News) - GSK PLC on Monday announced a global licence deal with Alfasigma Spa for the worldwide rights for linerixibat, an investigational tr...
LONDON BRIEFING: Astra drug wins US review as oil surges above USD100
(Alliance News) - AstraZeneca secures US priority review for Enhertu, GSK agrees linerixibat deal with Alfasigma, while AdvancedAdvT rules out M&C Saa...
Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute
March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settl...
TRADING UPDATES: Rosebank fundraise; Surface Transforms loses GM deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
LONDON BROKER RATINGS: Price targets raised for BP and Shell
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
Follow the stocks
